The presence of μ-opioid receptors was demonstrated as effects of receptor stimulation on PGE1-induced cAMP accumulation in neuronal-enriched primary cultures from rat cerebral cortex. Morphine was used as a μ-receptor agonist. There was a dose-dependent inhibition of the PGE1-stimulated cAMP accumulation by morphine, blocked by the μ-receptor antagonist naloxone. These findings suggest that these neuronal cultures express μ-receptors, possibly connected to adenylate cyclase via an inhibitory Gi-protein. The probable use of functional μ-receptors in neurotoxicological tests is discussed.
McLeanS., RothmanR.B., and HerkenhamM. (1986). Autoradiographic localization of μ- and δ-opiate receptors in the forebrain of the rat.Brain Research378, 49–60.
2.
MansourA., KhachaturianH., LewisM.E., AkilH., and WatsonS. (1987). Autoradiographic differentiation of mu, delta and kappa opioid receptors in the rat forebrain and midbrain.Journal of Neuroscience7, 2445–2464.
3.
LightmanS.L., NincovicM., HuntS.P., and IversenL. (1983). Evidence for opiate receptors on pituicyte.Nature305, 235–237.
4.
PearceB., Cambray-DeakinM., and MurphyS. (1985). Astrocyte opioid receptors: Activation modifies the noradrenaline-evoked increase in 2-[14C]deoxyglucose incorporation into glycogen.Neuroscience Letters55, 157–160.
5.
ChneiweissH., GlowinskiJ., and PremontJ. (1988). Mu and delta opiate receptors coupled negatively to adenylate cyclase on embryonic neurons from the mouse striatum in primary cultures.Journal of Neuroscience9, 3376–3382.
6.
WongY.H., Demilou-masonCD., and BarnardE.A. (1989). Opioid receptors in magnesium-digitonin-solubilized rat brain membranes are tightly coupled to a pertussis toxin-sensitive guanine nucleotide-binding protein.Journal of Neurochemistry52, 999–1009.
7.
SchoffelmeerA.N.M., HogenboomF., and MulderA.H. (1987). Inhibition of dopamine-sensitive adenylate cyclase by opioids: possible involvement of physically associated μ-and δ-opioid receptors.Archives of Pharmacology325, 278–284.
8.
LowryO.H., RosenbroughN.J., FarrA.L., and RandallR.J. (1951). Protein measurement with the Folin phenol reagent.Journal of Biological Chemistry193, 265–275.
9.
SteinerA.L., ParkerC.W., and KipnisD.M. (1972). Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides.Journal of Biological Chemistry247, 1106–1113.
10.
SteinerA.L., PagliaraA.S., ChaseL.R., and KipnisD.M. (1972). Radioimmunoassay for cyclic nucleotides. II. Adenosine 3',5′–monophosphate and guanosine 3',5′–monophosphate in mammalian tissues and body fluids.Journal of Biological Chemistry247, 1114–1120.
11.
MansourM.L., LewisM.E., KhachaturianH., AkilH., and WatsonS.J. (1986). Pharmacological and anatomical evidence of selective μ, δ and κ opioid receptor binding in rat brain.Brain Research399, 69–79.
12.
ZagonI.S., and McLaughlinP.J. (1983). Increased brain size and cellular content in infant rats treated with an opiate antagonist.Science221, 1179–1180.
13.
TraberJ., FischerK., LatzinS., and HamprechtB. (1975). Morphine antagonises action of prostaglandin in neuroblastoma and neuroblastoma x glioma hybrid cells.Nature253, 120–122.
14.
SöderbäckM., HanssonE., TottmarO., & RönnbäckL. (1989). Neurons in primary cultures from five defined rat brain regions — cellular composition and morphological appearance.Cellular and Molecular Biology35, 1–16.
15.
KitchenI., McDowellJ., WinderC., and WilsonJ.M. (1984). Low-level lead exposure alters morphine antinociception in neonatal rats.Toxicology Letters22, 119–123.
16.
McDowellJ., and KitchenI. (1988). Perinatal lead exposure alters the development of δ-but not μ-opioid receptors in the brain.British Journal of Pharmacology94, 933–937.
